These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
371 related articles for article (PubMed ID: 20599258)
1. Is adjuvant chemotherapy indicated in stage I pure immature ovarian teratoma (IT)? A multicentre Italian trial in ovarian cancer (MITO-9). Mangili G; Scarfone G; Gadducci A; Sigismondi C; Ferrandina G; Scibilia G; Viganò R; Tateo S; Villa A; Lorusso D Gynecol Oncol; 2010 Oct; 119(1):48-52. PubMed ID: 20599258 [TBL] [Abstract][Full Text] [Related]
2. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study. Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834 [TBL] [Abstract][Full Text] [Related]
3. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases]. Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380 [TBL] [Abstract][Full Text] [Related]
4. The benefits of comprehensive surgical staging in the management of early-stage epithelial ovarian carcinoma. Le T; Adolph A; Krepart GV; Lotocki R; Heywood MS Gynecol Oncol; 2002 May; 85(2):351-5. PubMed ID: 11972399 [TBL] [Abstract][Full Text] [Related]
5. [Clinical features and prognostic factors of malignant ovarian teratoma]. Jin FM; Zhu GZ; Feng YJ Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):427-30. PubMed ID: 12974088 [TBL] [Abstract][Full Text] [Related]
6. Pure ovarian immature teratoma, a unique and curable disease: 10 years' experience of 32 prospectively treated patients. Bonazzi C; Peccatori F; Colombo N; Lucchini V; Cantù MG; Mangioni C Obstet Gynecol; 1994 Oct; 84(4):598-604. PubMed ID: 7522313 [TBL] [Abstract][Full Text] [Related]
7. Conservative treatment in epithelial ovarian cancer: results of a multicentre study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer) and SFOG (Société Francaise d'Oncologie Gynécologique). Morice P; Leblanc E; Rey A; Baron M; Querleu D; Blanchot J; Duvillard P; Lhommé C; Castaigne D; Classe JM; Bonnier P; Hum Reprod; 2005 May; 20(5):1379-85. PubMed ID: 15817592 [TBL] [Abstract][Full Text] [Related]
8. Ovarian Sertoli-Leydig cell tumors. a retrospective MITO study. Sigismondi C; Gadducci A; Lorusso D; Candiani M; Breda E; Raspagliesi F; Cormio G; Marinaccio M; Mangili G Gynecol Oncol; 2012 Jun; 125(3):673-6. PubMed ID: 22446621 [TBL] [Abstract][Full Text] [Related]
9. Ovarian immature teratoma: treatment and outcome in a single institutional cohort. Vicus D; Beiner ME; Clarke B; Klachook S; Le LW; Laframboise S; Mackay H Gynecol Oncol; 2011 Oct; 123(1):50-3. PubMed ID: 21764111 [TBL] [Abstract][Full Text] [Related]
10. Pure Immature Teratoma of the Ovary in Adults: Thirty-Year Experience of a Single Tertiary Care Center. Alwazzan AB; Popowich S; Dean E; Robinson C; Lotocki R; Altman AD Int J Gynecol Cancer; 2015 Nov; 25(9):1616-22. PubMed ID: 26332392 [TBL] [Abstract][Full Text] [Related]
11. Role of staging surgery and adjuvant chemotherapy in adult patients with apparent stage I pure immature ovarian teratoma after fertility-sparing surgery. Wang D; Zhu S; Jia C; Cao D; Wu M; Shen K; Yang J; Xiang Y Int J Gynecol Cancer; 2020 May; 30(5):664-669. PubMed ID: 32179695 [TBL] [Abstract][Full Text] [Related]
13. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial. Trimbos JB; Vergote I; Bolis G; Vermorken JB; Mangioni C; Madronal C; Franchi M; Tateo S; Zanetta G; Scarfone G; Giurgea L; Timmers P; Coens C; Pecorelli S; J Natl Cancer Inst; 2003 Jan; 95(2):113-25. PubMed ID: 12529344 [TBL] [Abstract][Full Text] [Related]
14. [BEP/VIP in children and adolescents with malignant non-testicular germ cell tumors. A comparison of the results of treatment of therapy studies MAKEI 83/86 and 89P/89]. Göbel U; Calaminus G; Teske C; Bamberg M; Bökkerink JP; Haas RJ; Holschneider AM; Janka-Schaub G; Jürgens H; Mittler U Klin Padiatr; 1993; 205(4):231-40. PubMed ID: 7690864 [TBL] [Abstract][Full Text] [Related]
15. Outcome and reproductive function after cumulative high-dose combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for patients with ovarian endodermal sinus tumor. Kang H; Kim TJ; Kim WY; Choi CH; Lee JW; Kim BG; Bae DS Gynecol Oncol; 2008 Oct; 111(1):106-10. PubMed ID: 18656249 [TBL] [Abstract][Full Text] [Related]
19. Yolk sac tumours of the ovary: evaluation of clinicopathological features and prognostic factors. Cicin I; Saip P; Guney N; Eralp Y; Ayan I; Kebudi R; Topuz E Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):210-4. PubMed ID: 19419810 [TBL] [Abstract][Full Text] [Related]
20. Prognostic factors and role of salvage surgery in chemorefractory ovarian germ cell malignancies: a study in Chinese patients. Li J; Yang W; Wu X Gynecol Oncol; 2007 Jun; 105(3):769-75. PubMed ID: 17459461 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]